Cx601
Cx601-0302
Phase 3 other completed
Quick answer
Cx601 for Crohn's Disease is a Phase 3 program (other) at Takeda Pharmaceuticals International AG with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Crohn's Disease
- Phase
- Phase 3
- Modality
- other
- Status
- completed